68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)

• Status: Recruiting
• Trial end date: 2021-12-20
• Target enrollment: 0
• Participant gender: All

Summary

This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of origin of fever of unknown origin.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Carina Mari Aparici
• Treatments: Citric Acid; Gallium citrate; Sodium Citrate

Criteria

Inclusion Criteria:

• Patient is >/=18 years old at the time of the scan.

• Patient with diagnosis of FUO.

• Patient is capable of complying with study procedures.

• Patient can remain still for duration of imaging procedure.

• Able to provide written consent.

Exclusion Criteria:

• Patient is pregnant or nursing.

• Metallic implants (contraindicated for MRI).

• History of renal insufficiency (only for MRI contrast administration).

• Inability to lie still for the entire imaging time.

• Inability to complete the needed investigational and standard of care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.).

• Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the investigator, may significantly interfere with study compliance.

• Known allergy, hypersensitivity, or intolerance to the investigational product or its excipients.